New combo pill aims to end recurring vaginal infections
NCT ID NCT07483671
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether BPR-101 capsules, taken with the antibiotic metronidazole, can prevent bacterial vaginosis (BV) from coming back. Eighty women with BV will receive either the active treatment or a placebo. The main goal is to see if the combination lowers the rate of BV recurrence over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BPR-101 capsules
- What this could lead to
- If successful, this could lead to a new way to prevent bacterial vaginosis from coming back after treatment.
- What could go wrong
- This is an early phase IIb trial with only 80 participants, so results may not apply to everyone. The combination therapy might not reduce recurrence as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL VAGINOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tianjin Medical University General Hospital
Tianjin, 300000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Friendly bacteria vs. vaginal infections: a new trial puts probiotics to the test
- Can a simple Self-Test cut preterm births in High-Risk pregnancies?
- Vaginal device aims to boost infection treatment
- Blue light could soothe vaginal disorders without hormones
- New vaginal capsule aims to tackle stubborn bacterial vaginosis
- Can a probiotic stop bacterial vaginosis recurrence?